Clinical evaluation of recombinant human platelet - derived growth factor for the treatment of lower extremity diabetic ulcers

Journal of Vascular Surgery

Volumn 21, Issue 1, 1995, Pages 71-81

  Steed, David L ^a   Study Group, the Diabetic Ulcer ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELLULITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DIABETES MELLITUS; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; EDEMA; FEMALE; HUMAN; INFLUENZA; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TRANSCUTANEOUS OXYGEN MONITORING; TREATMENT OUTCOME; WOUND HEALING;

ADMINISTRATION, TOPICAL; CHRONIC DISEASE; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; RECOMBINANT PROTEINS; WOUND HEALING;

EID: 0028873980     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(95)70245-8     Document Type: Article

References (25)

1. Management of diabetic midfoot ulcers
2. Diabetic foot ulcers: pathogenesis and management
3. Wound therapy: growth factors as agents to promote healing
4. Growth factors: their biology and promise in dermatologic diseases and tissue repair
5. Role of platelet-derived growth factor in wound healing
6. Peptide regulatory factors: platelet derived growth factor
7. Is PDGF really important? Testing the hypothesis
8. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors
9. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats
10. Platelet-derived growth factor (BB homodimer), transforming growth factor-ß1, and basic fibroblast growth factor in dermal wound healing
11. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers
12. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers
13. Measurement of transcutaneous oxygen pressure in normal and ischaemic skin
14. Transcutaneous oxygen tension measurements on limbs of diabetic and nondiabetic patients with peripheral vascular disease
15. Utility of transcutaneous oxygen tension measurements in peripheral arterial occlusive disease
16. Dose responsive effects of PDGF-BB, PDGF-AA, EGF and bFGF on granulation tissue in a guinea pig partial thickness skin excision model
17. The biology of platelet-derived growth factor
18. The molecular biology of platelet-derived growth factor
19. Classification and treatment of chronic nonhealing wounds: successful treatment with autologous platelet-derived wound healing factors (PDWHF)
20. Stimulation of repair of chronic nonhealing, cutaneous ulcers using platelet-derived wound healing formula
21. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers
22. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report
23. Stimulation of healing of chronic wounds by epidermal growth factor
24. Topical use of recombinant epidermal growth factor (h-EGF) in venous ulcers